GLP-1 coverage in employer plans could double in 2024Findings from a recent employer survey on sentiment and adoption of GLP-1 medications by Accolade and Savanta on sentiment and adoption...
Bariatric surgery cures urinary incontinence in one of three womenBariatric surgery is able to cure urinary incontinence in one of three women with obesity and a significant improvement was obtained in...
Clinical trial of MBX 1416 for Post-Bariatric Hypoglycemia beginsThe first participant has been dosed in MBX Biosciences’ Phase 1/2 clinical trial of MBX 1416, the company’s long-acting glucagon-like...
Phase III studies to investigate survodutide for people living with obesity and overweightBoehringer Ingelheim and Zealand Pharma have initiated three Phase III trials investigating survodutide (also known as BI 456906) for...
First patient treated with SiPore21 for sustained diabetes and obesity controlThe first patient has been treated with Sigrid Therapeutics’ SiPore21, an innovative medical device designed for sustained diabetes and...
Study links GLP-1s with serious gastrointestinal conditionsGlucagon-like peptide-1 (GLP-1) agonists are associated with an increased risk of serious medical conditions including stomach paralysis,...
Standardisation of OAGB is key to reducing surgical errors and ensuring consistent patient outcomes2 days ago